BioInvent publishes prospectus regarding admission to trading of newly issued shares on Nasdaq Stockholm
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, UNITED KINGDOM OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES.Lund, Sweden – March 26, 2021 – The prospectus regarding admission to trading of 16,260,601 newly issued shares on Nasdaq Stockholm as a result of the directed issue of shares resolved by the Board of Directors of BioInvent on February 23,